139 related articles for article (PubMed ID: 3061035)
41. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
[TBL] [Abstract][Full Text] [Related]
42. [Intra-arterial drug therapy in arterial obstructions of the leg: value of high concentrations in the ischemic zones].
Jorns G
Phlebologie; 1979; 32(1):43-6. PubMed ID: 432288
[No Abstract] [Full Text] [Related]
43. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
44. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
[No Abstract] [Full Text] [Related]
45. [Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].
Mangiafico RA; Malatino LS; Attinà T; Dell'Arte S; Messina R
Minerva Cardioangiol; 1999 Dec; 47(12):652-3. PubMed ID: 10670246
[No Abstract] [Full Text] [Related]
46. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
Dé P; Hepp W
Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
[No Abstract] [Full Text] [Related]
47. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
Hirai M; Nanki M; Nakayama R
Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
[TBL] [Abstract][Full Text] [Related]
48. [Pharmacologic concepts for clinical use of prostaglandin E1].
Schrör K
Vasa Suppl; 1991; 33():335-6. PubMed ID: 1788746
[TBL] [Abstract][Full Text] [Related]
49. Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
Nielsen PE; Holstein P; Nielsen SL; Poulsen HL
Bibl Anat; 1975; 13():305-6. PubMed ID: 1231765
[No Abstract] [Full Text] [Related]
50. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
51. [Results of modified ultra-high streptokinase lysis in patients with arterial occlusive disease. Preliminary report].
Schmidtke I
Vasa Suppl; 1993; 39():14-6. PubMed ID: 8322119
[TBL] [Abstract][Full Text] [Related]
52. Prostaglandin therapy of peripheral occlusive arterial disease.
Linhart J
Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
[TBL] [Abstract][Full Text] [Related]
53. [Hemodynamic study by pulsed ultrasonic velocimetry of axillo-femoral bypass].
Levy BI; Michel JB; Bailliart O; Lagneau P
Arch Mal Coeur Vaiss; 1981 Aug; 74(8):979-84. PubMed ID: 6793013
[TBL] [Abstract][Full Text] [Related]
54. [The role of intra-operative Prostavasin application during crural bypass surgery].
Thul R; Heckenkamp J; Gawenda M; Reichert V; Aleksic M; Brunkwall J
Zentralbl Chir; 2007 Dec; 132(6):485-90. PubMed ID: 18098074
[TBL] [Abstract][Full Text] [Related]
55. [Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?].
Schweizer J; Kaulen R; Altmann E; Nierade A; Nanning T
Z Kardiol; 1996 Mar; 85(3):193-7. PubMed ID: 8659199
[TBL] [Abstract][Full Text] [Related]
56. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
57. Effect of prostaglandin E1 on blood flow in normal and ischemic canine hindlimbs.
Pasch AR; Ricotta JJ; Burke AR; O'Mara RE; DeWeese JA; Wilson G
Surgery; 1984 Jun; 95(6):724-9. PubMed ID: 6539509
[TBL] [Abstract][Full Text] [Related]
58. [Results of the treatment of acute ischemia of the legs with small intra-arterial doses of streptokinase].
Wiechowski S; Filipiak K; Brykczyński M; Listewnik M; Syberyjski R
Pol Tyg Lek; 1988 Aug; 43(34):1088-91. PubMed ID: 3251198
[No Abstract] [Full Text] [Related]
59. Ticlopidine in the treatment of peripheral occlusive arterial disease.
Arcan JC; Panak E
Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
[No Abstract] [Full Text] [Related]
60. [Can vasomotion be modified by vasoactive substances or hemodilution?].
Tischler R; Decrinis M; Skursky-Roller R
Acta Med Austriaca; 1994; 21(5):133-6. PubMed ID: 7709711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
